(36) suggested that icariin could alleviate RA by inhibiting the expression of osteoclast markers (β3 integrin, cathepsin K and MMP-9), reducing the number of Th17 cells, and inhibiting STAT3 activation-mediated IL-17 production. The gene discussed is IL17A; the disease is rheumatoid arthritis.